The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Open accessAbstract
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the heart to increased workload, a cardiac insult such as a heart attack or genetic mutation. Cardiac hypertrophy is usually characterized by an increase in cardiomyocyte size and thickening of ventricular walls. Initially, such growth is an adaptive response to maintain cardiac function; however, in settings of sustained stress and as time progresses, these changes become maladaptive and the heart ultimately fails. In this review, we discuss the key features of pathological cardiac hypertrophy and the numerous mediators that have been found to be involved in the pathogenesis of cardiac hypertrophy affecting gene transcription, calcium handling, protein synthesis, metabolism, autophagy, oxidative stress and inflammation. We also discuss new mediators including signaling proteins, microRNAs, long noncoding RNAs and new findings related to the role of calcineurin and calcium-/calmodulin-dependent protein kinases. We also highlight mediators and processes which contribute to the transition from adaptive cardiac remodeling to maladaptive remodeling and heart failure. Treatment strategies for heart failure commonly include diuretics, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers and β-blockers; however, mortality rates remain high. Here, we discuss new therapeutic approaches (e.g., RNA-based therapies, dietary supplementation, small molecules) either entering clinical trials or in preclinical development. Finally, we address the challenges that remain in translating these discoveries to new and approved therapies for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–464 of 464
Histone deacetylase signaling in cardioprotection
Lehmann, L., Worst, B. C., Stanmore, D. A., & Backs, J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1516-9 · Cited by 65
Pantos, C., Mourouzis, I. S., Galanopoulos, G. T., Gavra, M., Périmenis, P., Spanou, D., & Cokkinos, D. V. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1255035 · Cited by 65
Omori, Y., Ohtani, T., Sakata, Y., Mano, T., Takeda, Y., Tamaki, S., Tsukamoto, Y., Kamimura, D., Aizawa, Y., 剛, 三., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283569c5a · Cited by 64
Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts
Liedtke, A. J., Demaison, L., & Nellis, S. H. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.1.h169 · Cited by 64
Cardiovascular gene therapy for myocardial infarction
Scimia, M. C., Gumpert, A. M., & Koch, W. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866085 · Cited by 63
Embryonic Stem Cell–Derived Cardiac Myocytes Are Not Ready for Human Trials
Anderson, M. E., Goldhaber, J. I., Houser, S. R., Pucéat, M., & Sussman, M. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.304616 · Cited by 63
PKC-β is not necessary for cardiac hypertrophy
Roman, B. B., Geenen, D. L., Leitges, M., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2264 · Cited by 62
Oleic acid mitigates TNF-α-induced oxidative stress in rat cardiomyocytes
Al‐Shudiefat, A. A., Sharma, A. K., Bagchi, A. K., Dhingra, S., & Singal, P. K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1447-z · Cited by 61
Mourouzis, I. S., Mantzouratou, P., Galanopoulos, G. T., Kostakou, E., Roukounakis, N., Kokkinos, A. D., Cokkinos, D. V., & Pantos, C. I. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1175-9 · Cited by 61
Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1
Roy, S. G., Mishra, S., Ghosh, G., & Bandyopadhyay, A. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.12.005 · Cited by 61
What Is an Angiotensin Converting Enzyme Inhibitor?
Sweitzer, N. K. (2003) · Circulation · doi:10.1161/01.cir.0000075957.16003.07 · Cited by 60
Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model
Kitamura, K., Shibata, R., Tsuji, Y., Shimano, M., Inden, Y., & Murohara, T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00771.2010 · Cited by 59
Acute T3 treatment protects the heart against ischemia-reperfusion injury via TRα1 receptor
Pantos, C. I., Mourouzis, I. S., Saranteas, T., Brozou, V., Galanopoulos, G. T., Kostopanagiotou, G. G., & Cokkinos, D. V. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0791-8 · Cited by 58
Samanen, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397176-0.00005-4 · Cited by 57
Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure
Lindner, M., Brandt, M. C., Sauer, H., Hescheler, J., Böhle, T., & Beuckelmann, D. J. (2002) · Cell Calcium · doi:10.1054/ceca.2002.0272 · Cited by 57
Rengo, G., Cannavò, A., Liccardo, D., Zincarelli, C., de Lucia, C., Pagano, G., Komici, K., Parisi, V., Scala, O., Agresta, A., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000329 · Cited by 56
Guo, D., Kassiri, Z., Basu, R., Chow, F. L., Kandalam, V., Damilano, F., Liang, W., Izumo, S., Hirsch, E., Penninger, J. M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.229054 · Cited by 56
Dijkstra, S. C., Brouwer, I. A., van Rooij, F. J. A., Hofman, A., Witteman, J. C. M., & Geleijnse, J. M. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp126 · Cited by 55
Kiriazis, H., Wang, K. K., Xu, Q., Gao, X., Ming, Z., Su, Y. R., Moore, X., Lambert, G. W., Gibbs, M. E., Dart, A. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707622 · Cited by 54
Vanderheyden, M., Paulus, W. J., Voss, M., Knuefermann, P., Sivasubramanian, N., Mann, D., & Baumgarten, G. (2005) · Heart · doi:10.1136/hrt.2004.035733 · Cited by 52
Morissette, M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00212-8 · Cited by 52
Cittadini, A., Monti, M. G., Iaccarino, G., Castiello, M. C., Baldi, A., Bossone, E., Longobardi, S., Marra, A. M., Petrillo, V., Saldamarco, L., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs261 · Cited by 52
Exercise-mediated regulation of Hsp70 expression following aerobic exercise training
Melling, C. W. J., Thorp, D. B., Milne, K. J., Krause, M. P., & Noble, E. G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00827.2007 · Cited by 48
Alterations in ryanodine receptors and related proteins in heart failure
Ather, S., Respress, J. L., Li, N., & Wehrens, X. H. T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.008 · Cited by 47
Serum but not myocardial TNF-α concentration is increased in pacing-induced heart failure in rabbits
Aker, S., Belosjorow, S., Konietzka, I., Duschin, A., Martin, C., Heusch, G., & Schulz, R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2003 · Cited by 46
Bossuyt, J., Chang, C.-W., Helmstadter, K. G., Kunkel, M. T., Newton, A. C., Campbell, K. S., Martin, J. W., Bossuyt, S., Robia, S. L., & Bers, D. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246447 · Cited by 45
Yang, K., Jay, P. Y., McMullen, J. R., & Nerbonne, J. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr283 · Cited by 44
Self-citationRoles and post‐translational regulation of cardiac class IIa histone deacetylase isoforms
Weeks, K. L., & Avkiran, M. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282442 · Cited by 42
Self-citationPI3Kγ Protects from Myocardial Ischemia and Reperfusion Injury through a Kinase-Independent Pathway
Haubner, B. J., Neely, G. G., Voelkl, J. G. J., Damilano, F., Kuba, K., Imai, Y., Komnenovic, V., Mayr, A., Pachinger, O. M., Hirsch, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009350 · Cited by 40
Recent progress in research on molecular mechanisms of autophagy in the heart
Maejima, Y., Chen, Y., Isobe, M., Gustafsson, Å. B., Kitsis, R. N., & Sadoshima, J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00711.2014 · Cited by 39
Huang, X., Fan, R., Lu, Y., Chang, Y., Xu, X., Zhang, X., Liu, P., Yan, S., Chen, C., & Wang, L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3272-9 · Cited by 38
Aldosterone, Mineralocorticoid Receptor Activation, and Cardiovascular Remodeling
Leopold, J. A. (2011) · Circulation · doi:10.1161/circulationaha.111.067918 · Cited by 37
Long-term simulated microgravity causes cardiac RyR2 phosphorylation and arrhythmias in mice
Respress, J. L., Гершович, П. М., Wang, T., Reynolds, J. O., Skapura, D. G., Sutton, J. P., Miyake, C. Y., & Wehrens, X. H. T. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.138 · Cited by 36
Protein Kinases as Drug Development Targets for Heart Disease Therapy
Dhalla, N. S., & Muller, A. L. (2010) · Pharmaceuticals · doi:10.3390/ph3072111 · Cited by 36
Janssen, R., Zuidwijk, M. J., Kuster, D. W. D., Muller, A., & Simonides, W. S. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00171 · Cited by 36
Literáti-Nagy, B., Péterfai, E., Kulcsár, E., Literáti-Nagy, Z., Buday, B., Tory, K., Mandl, J., Sümegi, B., Fleming, A., Roth, J., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.09.005 · Cited by 35
Sheetz, M. J., Aiello, L. P., Shahri, N., Davis, M. D., Kles, K. A., & Danis, R. P. (2011) · Retina · doi:10.1097/iae.0b013e3181fe545f · Cited by 35
Serati, A. R., Motamedi, M. R., Emami, S., Varedi, P., & Movahed, M. R. (2010) · Cardiology · doi:10.1159/000318810 · Cited by 34
Regulation of JAK/STAT signalling by SOCS in the myocardium
Shi, J., & Wei, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs321 · Cited by 34
Recent Progress in Heart Failure Treatment and Heart Transplantation
Augoustides, J. G., & Říha, H. (2009) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2009.06.009 · Cited by 33
Bienvenu, L. A., Reichelt, M. E., Delbridge, L. M. D., & Young, M. J. (2013) · Clinical Science · doi:10.1042/cs20130050 · Cited by 32
ROLE OF INSULIN‐LIKE GROWTH FACTOR 1 AND PHOSPHOINOSITIDE 3‐KINASE IN A SETTING OF HEART DISEASE
McMullen, J. R. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04873.x · Cited by 32
Self-citationAutophagy in the Heart: Too Much of a Good Thing?
Wang, E. Y., Biala, A. K., Gordon, J. W., & Kirshenbaum, L. A. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31824cc427 · Cited by 31
Belakavadi, M., Saunders, J., Weisleder, N. L., Raghava, P. S., & Fondell, J. D. (2010) · Endocrinology · doi:10.1210/en.2009-1241 · Cited by 31
A Review of Cardiac Transplantation
Fischer, S., & Glas, K. E. (2013) · Anesthesiology Clinics · doi:10.1016/j.anclin.2013.01.003 · Cited by 30
PI3K Inhibitors as Novel Cancer Therapies: Implications for Cardiovascular Medicine
McLean, B. A., Zhabyeyev, P., Pituskin, E., Paterson, D. I., Haykowsky, M. J., & Oudit, G. Y. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.02.005 · Cited by 26
Fatty acids and cardiac disease: fuel carrying a message
van Bilsen, M., & Planavila, A. (2014) · Acta Physiologica · doi:10.1111/apha.12308 · Cited by 25
Ishiwata, T., Orosz, A., Wang, X., Mustafi, S. B., Pratt, G. W., Christians, E., Boudina, S., Abel, E. D., & Benjamin, I. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042118 · Cited by 22
den Ruijter, H. M., Verkerk, A. O., Schumacher, C. A., Houten, S. M., Belterman, C. N. W., Baartscheer, A., Brouwer, I. A., van Bilsen, M., de Roos, B., & Coronel, R. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.963116 · Cited by 22
Ibáñez, B., Macaya, C., Sánchez-Brunete, V., Pizarro, G., Fernández‐Friera, L., Rodríguez, A. A. M., Fernández‐Ortíz, A., García-Ruiz, J. M., García‐Álvarez, A., Íñiguez, A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.009352 · Cited by 21
Liu, J., Chan, P., Chen, J.-J., Lee, H.-M., Lee, W., Shih, N., Chen, Y., Hong, H.-J., & Cheng, T. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256544 · Cited by 21
Role of PI3 Kinase Gamma in Excitation-Contraction Coupling and Heart Disease
Oudit, G. Y., & Kassiri, Z. (2007) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152907782793545 · Cited by 21
Translational potential of thyroid hormone and its analogs
Arsanjani, R., McCarren, M., Bahl, J. J., & Goldman, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.012 · Cited by 20
Cytokines Are Not a Requisite Part of the Pathophysiology Leading to Cardiac Decompensation
Recchia, F. A., Bernstein, R. D., Sehgal, P. B., Ferreri, N. R., & Hintze, T. H. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22306.x · Cited by 18
MicroRNAs and the Heart: Small Things Do Matter
Papoutsidakis, N., Deftereos, S. G., Kaoukis, A., et al. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313020009 · Cited by 17
The Non-coding Road Towards Cardiac Regeneration
Hudson, J. E., & Porrello, E. R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9486-8 · Cited by 16
Targeting the mineralocorticoid receptor in cardiovascular disease
Young, M. J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.748750 · Cited by 15
Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse
Montano, M. M., Desjardins, C. L., Doughman, Y. Q., Hsieh, Y., Hu, Y., Bensinger, H. M., Wang, C., Stelzer, J. E., Dick, T. E., Hoit, B. D., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt086 · Cited by 14
DISTINCT ROLE OF ADRENOCEPTOR SUBTYPES IN CARDIAC ADAPTATION TO CHRONIC PRESSURE OVERLOAD
Du, X. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04871.x · Cited by 12
Murry, C. E., Chong, J. J. H., & Laflamme, M. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.305042 · Cited by 12
Lee, S., Kim, H., Kim, Y.-J., Oh, S., & Sohn, D. (2014) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2014.22.2.72 · Cited by 9
Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium
Scimia, M. C., Cannavò, A., & Koch, W. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.818813 · Cited by 9
MicroRNAs in the Stressed Heart: Sorting the Signal from the Noise
Matkovich, S. J. (2014) · Cells · doi:10.3390/cells3030778 · Cited by 7
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Cluntun, A. A., Badolia, R., Lettlova, S., Parnell, K. M., Shankar, T. S., Diakos, N. A., Olson, K. A., Taleb, I., Tatum, S. M., Berg, J. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.003 · Cited by 345
The role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Gélinas, R., Mailleux, F., Dontaine, J., Bultot, L., Demeulder, B., Ginion, A., Daskalopoulos, E. P., Esfahani, H., Dubois-Deruy, E., Lauzier, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02795-4 · Cited by 253
Metadata
- Authors
- Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R.
- Venue
- Archives of Toxicology
- Published
- 2015-02-24
- Volume
- 89
- Issue
- 9
- Pages
- 1401-1438
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W1989434611
- Cited by
- 708
- References
- 464
- FWCI
- 24.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.